Senti Biosciences Holdings, Inc.
SNTI
$0.96
-$0.01-0.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -61.44M | -47.58M | -58.32M | -54.79M | -52.79M |
| Total Depreciation and Amortization | 3.64M | 3.68M | 3.72M | 3.78M | 3.84M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.80M | -8.50M | 6.42M | 3.83M | 1.48M |
| Change in Net Operating Assets | 3.56M | 2.33M | -318.00K | 3.42M | 6.07M |
| Cash from Operations | -43.44M | -50.07M | -48.49M | -43.77M | -41.40M |
| Capital Expenditure | -196.00K | -207.00K | -207.00K | -11.00K | -26.00K |
| Sale of Property, Plant, and Equipment | 12.00K | 12.00K | 72.00K | 60.00K | 60.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -184.00K | -195.00K | -135.00K | 49.00K | 34.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.18M | 49.72M | 49.59M | 49.06M | 49.06M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 581.00K | 2.29M | 4.73M | 4.26M | 4.67M |
| Cash from Financing | 11.76M | 52.01M | 54.33M | 53.32M | 53.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.87M | 1.74M | 5.70M | 9.60M | 12.37M |